207 related articles for article (PubMed ID: 19222830)
1. Incidence and risk factors for development of malignant neoplasia after feline renal transplantation and cyclosporine-based immunosuppression.
Schmiedt CW; Grimes JA; Holzman G; McAnulty JF
Vet Comp Oncol; 2009 Mar; 7(1):45-53. PubMed ID: 19222830
[TBL] [Abstract][Full Text] [Related]
2. Post-transplant malignant neoplasia associated with cyclosporine-based immunotherapy: prevalence, risk factors and survival in feline renal transplant recipients.
Wormser C; Mariano A; Holmes ES; Aronson LR; Volk SW
Vet Comp Oncol; 2016 Dec; 14(4):e126-e134. PubMed ID: 25303015
[TBL] [Abstract][Full Text] [Related]
3. Incidence of and risk factors for diabetes mellitus in cats that have undergone renal transplantation: 187 cases (1986-2005).
Case JB; Kyles AE; Nelson RW; Aronson L; Kass PH; Klose TC; Bailiff NL; Gregory CR
J Am Vet Med Assoc; 2007 Mar; 230(6):880-4. PubMed ID: 17362164
[TBL] [Abstract][Full Text] [Related]
4. One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre.
McGeown MG; Douglas JF; Middleton D
Clin Transpl; 2000; ():193-202. PubMed ID: 11512313
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for malignancy in Japanese renal transplant recipients.
Imao T; Ichimaru N; Takahara S; Kokado Y; Okumi M; Imamura R; Namba Y; Isaka Y; Nonomura N; Okuyama A
Cancer; 2007 May; 109(10):2109-15. PubMed ID: 17407138
[TBL] [Abstract][Full Text] [Related]
6. Excess risk of cancer in renal transplant patients.
Kessler M; Jay N; Molle R; Guillemin F
Transpl Int; 2006 Nov; 19(11):908-14. PubMed ID: 17018126
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal fibrosis in feline renal transplant recipients: 29 cases (1998-2011).
Wormser C; Phillips H; Aronson LR
J Am Vet Med Assoc; 2013 Dec; 243(11):1580-5. PubMed ID: 24261808
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors of new-onset diabetes mellitus after renal transplantation.
Chien YS; Chen YT; Chuang CH; Cheng YT; Chuang FR; Hsieh H
Transplant Proc; 2008 Sep; 40(7):2409-11. PubMed ID: 18790250
[TBL] [Abstract][Full Text] [Related]
9. Renal transplantation in cats with calcium oxalate urolithiasis: 19 cases (1997-2004).
Aronson LR; Kyles AE; Preston A; Drobatz KJ; Gregory CR
J Am Vet Med Assoc; 2006 Mar; 228(5):743-9. PubMed ID: 16506941
[TBL] [Abstract][Full Text] [Related]
10. Malignancies in renal transplantation: an unmet medical need.
Dantal J; Pohanka E
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i4-10. PubMed ID: 17456618
[TBL] [Abstract][Full Text] [Related]
11. Characterization of post transplantation lymphoma in feline renal transplant recipients.
Durham AC; Mariano AD; Holmes ES; Aronson L
J Comp Pathol; 2014; 150(2-3):162-8. PubMed ID: 24016783
[TBL] [Abstract][Full Text] [Related]
12. Renal transplants in cats: 66 cases (1987-1996).
Mathews KG; Gregory CR
J Am Vet Med Assoc; 1997 Dec; 211(11):1432-6. PubMed ID: 9394895
[TBL] [Abstract][Full Text] [Related]
13. Survival, complications, and analysis of risk factors after renal transplantation in cats.
Schmiedt CW; Holzman G; Schwarz T; McAnulty JF
Vet Surg; 2008 Oct; 37(7):683-95. PubMed ID: 19134091
[TBL] [Abstract][Full Text] [Related]
14. [Malignant neoplasia and kidney transplantation. Retrospective analysis of data on the population having kidney transplantation with de novo neoplasia in the setting of the AIRT].
Stallone G; Infante B; Schena A; Grandaliano G; Di Paolo S; Scolari MP; Stefoni S; Zanazzi M; Salvadori M; Savazzi AM; Albertazzi A; Cornella C; Turello E; Schena FP
G Ital Nefrol; 2003; 20(6):611-4. PubMed ID: 14732914
[TBL] [Abstract][Full Text] [Related]
15. Acute toxoplasmosis following renal transplantation in three cats and a dog.
Bernsteen L; Gregory CR; Aronson LR; Lirtzman RA; Brummer DG
J Am Vet Med Assoc; 1999 Oct; 215(8):1123-6. PubMed ID: 10530326
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of malignant neoplasia in feline renal-transplant recipients.
Wooldridge JD; Gregory CR; Mathews KG; Aronson LR; Kyles AE
Vet Surg; 2002; 31(1):94-7. PubMed ID: 11778173
[TBL] [Abstract][Full Text] [Related]
17. Increasing transplant cancer patient survival by conversion of immunosuppressive agents.
Chuang FR; Hsieh H; Hsu KT; Huang HF
Transplant Proc; 1996 Jun; 28(3):1346-7. PubMed ID: 8658687
[No Abstract] [Full Text] [Related]
18. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
Chadban S
Nephrol Dial Transplant; 2008 Jun; 23(6):1816-8. PubMed ID: 18326882
[No Abstract] [Full Text] [Related]
19. [Malignant neoplasias in renal transplantation recipients].
Gómez-Roel X; León-Rodríguez E
Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal effusion in cats: 65 cases (1981-1997).
Wright KN; Gompf RE; DeNovo RC
J Am Vet Med Assoc; 1999 Feb; 214(3):375-81. PubMed ID: 10023401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
